ALEXION PHARMACEUTICALS INC 4
4 · ALEXION PHARMACEUTICALS INC · Filed Feb 8, 2017
Insider Transaction Report
Form 4
Carmichael Clare
SVP, Chief HR Officer
Transactions
- Sale
Common Stock, par value $.0001 per share
2017-02-06$125.69/sh−3,380$424,832→ 35,197 total - Sale
Common Stock, par value $.0001 per share
2017-02-06$126.65/sh−24$3,040→ 35,173 total - Sale
Common Stock, par value $.0001 per share
2017-02-07$128.09/sh−166$21,263→ 35,007 total
Footnotes (5)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $125.00 - $125.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $126.00 - $126.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $128.00 - $128.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.